Prenatal Invasive Procedures in Women With Hepatitis B, Hepatitis C, and/or Human Immunodeficiency Virus Infections

Journal of Obstetrics and Gynaecology Canada

Volumn 36, Issue 7, 2014, Pages 648-653

  Gagnon, Alain ^a   Davies, Gregory ^a   Wilson, R Douglas ^a   Audibert, Francois ^a   Brock, Jo Ann ^a   Campagnolo, Carla ^a   Carroll, June ^a   Chitayat, David ^a   Johnson, Jo Ann ^a   MacDonald, William ^a   Murphy Kaulbeck, Lynn ^a   Okun, Nanette ^a   Pastuck, Melanie ^b  

^a NONE   (Canada)

^b NONE   (Canada)

Author keywords

Amniocentesis; Chorionic villus sampling; Genetics; Human immunodeficiency virus; Pregnancy; Prenatal diagnosis; Viral hepatitis

Indexed keywords

AMNIOCENTESIS; ARTICLE; DATA ANALYSIS; DISEASE ASSOCIATION; FETUS MORBIDITY; FETUS MORTALITY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INVASIVE PROCEDURE; MORBIDITY; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRENATAL CARE; PRENATAL SCREENING; PREVALENCE; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; UTERUS DISEASE; VERTICAL TRANSMISSION; VIRUS IDENTIFICATION;

EID: 84922335216     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30546-6     Document Type: Article

References (35)

1. Langlois S., Brock J.-A. SOCG Genetics Committee. Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. SOGC Committee Opinion, No. 287, February 2013. J Obstet Gynaecol Can 2013, 35:177-181.
2. Delage G., Montplaisir S., Remy-Prince S., Pierri E. Prevalence of hepatitis B virus infection in pregnant women in the Montreal area. Can Med Assoc J 1986, 134:897-901.
3. Healy C.M., Cafferkey M.T., Butler K.M., Cahill I., McMorrow J., Philbin M., et al. Antenatal hepatitis B screening - is there a need for a national policy?. Ir Med J 2001, 94:111-112. 114.
4. Miranda A.E., Alves M.C., Neto R.L., Areal K.R., Gerbase A.C. Seroprevalence of HIV, hepatitis B virus, and syphilis in women at their first visit to public antenatal clinics in Vitoria, Brazil. Sex Transm Dis 2001, 28:710-713.
5. Centers for Disease Control and Prevention Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee. Morb Mortal Wkly Rep 1990, 39:1-26.
6. Towers C.V., Asrat T., Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol 2001, 184:1514-1518.
7. Alexander J.M., Ramus R., Jackson G., Sercely B., Wendel G.D. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol 1999, 7:283-286.
8. Grosheide P.M., Quartero H.W., Schalm S.W., Heijtink R.A., Christiaens G.C. Early invasive prenatal diagnosis in HbsAg-positive women. Prenat Diagn 1994, 14:553-558.
9. Ko T.M., Tseng L.H., Chang M.H., Chen D.S., Hsieh F.J., Chuang S.M., et al. Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection. Arch Gynecol Obstet 1994, 255:25-30.
10. Centers for Disease Control Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: immunization of infants, children, and adolescents. Morb Mortal Wkly Rep 1991, 40(RR-13):1-19.
11. Healy C.M., Cafferkey M.T., Conroy A., Dooley S., Hall W.W., Beckett M., et al. Hepatitis C infection in an Irish antenatal population. Ir J Med Sci 2000, 169:180-182.
12. Ford P.M., White C., Kaufmann H., MacTavish J., Pearson M., Ford S., et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ 1995, 153:1605-1609.
13. Blasig A., Wagner E.C., Pi D., Bigham M., Remple V.P., Craib K.J.P., et al. Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods. Can J Public Health 2011, 102:98-102.
14. Goldberg D., McIntyre P.G., Smith R., Appleyard K., Dunlop J., Taylor A., et al. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing. Br J Obstet Gynaecol 2001, 108:365-370.
15. Ohto H., Terazawa S., Sasaki N., Sasaki N., Hino K., Ishiwata C., et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994, 330:744-750.
16. Hillemanns P., Dannecker C., Kimmig R., Hasbargen U. Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy. Acta Obstet Gynecol Scand 2000, 79:543-547.
17. Conte D., Fraquelli M., Prati D., Colucci A., Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000, 31:751-755.
18. European Paediatric Hepatitis C Virus Network Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. Br J Obstet Gynaecol 2001, 108:371-377.
19. Delamare C., Carbonne B., Heim N., Berkane N., Petit J.C., Uzan S., et al. Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study. J Hepatol 1999, 31:416-420.
20. Poiraud S., Cohen J., Amiot X., Berkane N., Flahauif A., Dussaix E., et al. Mother to child transmission of hepatitis C virus: a case-control study of risk factors. Gastroenterology 2001, (Suppl A). A-366.
21. Cohen J., Dessaix E., Bernard O. Transmission du virus de l'hépatite C de la mère à l'enfant: une étude de 44 enfants. Gastroenterol Biol Clin 1998, 22:A179.
22. Minola E., Maccabruni A., Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus. Hepatology 2001, 33:1341-1342.
23. Patrick D.M., Money D.M., Forbes J., Dobson S.R., Rekart M.L., Cook D.A., et al. Routine prenatal screening for HIV in a low-prevalence setting. CMAJ 1998, 159:942-947.
24. Guinan M.E., Hardy A. Epidemiology of AIDS in women in the United States. 1981 through 1986. J Am Med Assoc 1987, 257:2039-2042.
25. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331:1173-1180.
26. Carpenter C.C., Fischl M.A., Hammer S.M., Hirsch M.S., Jacobsen D.M., Katzenstein D.A., et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 1998, 280:78-86.
27. Loutfy M.R., Margolese S., Money D.M., Gysler M., Hamilton S., Yudin M.H. Canadian HIV Pregnancy Planning Guideline Development Team. SOGC Clinical Practice Guideline, No. 278, June 2012. J Obstet Gynaecol Can 2012, 34:575-590.
28. Mandelbrot L., Mayaux M.J., Bongain A., Berrebi A., Moudoub-Jeanpetit Y., Benifla J.L., et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996, 175:661-667.
29. López M., Coll O. Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations. Fetal Diagn Ther 2010, 28:1-8.
30. Ducarme G., Ceccaldi P.F., Bernuau J., Luton D. Amniocentesis and viral risk (hepatitis B, C and HIV). J Gynecol Obstet Biol Reprod 2009, 38:469-473.
31. Low-Beer N.M., Penn Z.J. Management of HIV in pregnancy. RCOG Green-top Guideline No. 39 2010, Royal College of Obstetricians and Gynaecologists, London.
32. Westling K., Pettersson K., Kaldma A., Navér L. Rapid decline in HIV viral load when introducing raltegravir-containing antiretroviral treatment late in pregnancy. AIDS Patient Care STDS 2012, 26:714-717.
33. Somigliana E., Bucceri A.M., Tibaldi C., Alberico S., Ravizza M., Savasi V., et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series. Am J Obstet Gynecol 2005, 193:437-442.
34. Giorlandino C., Gambuzza G., D'Alessio P., Santoro M.L., Gentili P., Vizzone A. Blood contamination of amniotic fluid after amniocentesis in relation to placental location. Prenat Diagn 1996, 16:180-182.
35. Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169:207-208.